Opaleye Management Inc. - LUMOS PHARMA INC ownership

LUMOS PHARMA INC's ticker is LUMO and the CUSIP is 55028X109. A total of 39 filers reported holding LUMOS PHARMA INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Opaleye Management Inc. ownership history of LUMOS PHARMA INC
ValueSharesWeighting
Q3 2022$412,000
+148.2%
46,576
+116.4%
0.17%
+126.7%
Q2 2022$166,000
-95.7%
21,520
-94.4%
0.08%
-88.2%
Q2 2021$3,820,000
-13.4%
382,000
+1.4%
0.63%
-2.2%
Q1 2021$4,410,000
-56.1%
376,900
+34.0%
0.65%
-50.6%
Q4 2020$10,045,000
+201.7%
281,287
+16.8%
1.31%
+101.5%
Q3 2020$3,329,000240,8920.65%
Other shareholders
LUMOS PHARMA INC shareholders Q3 2020
NameSharesValueWeighting ↓
Lion Point Capital, LP 407,192$5,627,0001.23%
Opaleye Management Inc. 240,892$3,329,0000.65%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 936,291$12,940,0000.32%
NEA Management Company, LLC 526,663$7,278,0000.31%
Investors Financial Group, LLC 21,766$301,0000.22%
Wealth Advisors of Iowa, LLC 11,760$163,0000.11%
Blackstone Inc. 468,145$6,470,0000.02%
Jefferies Group LLC 120,651$1,667,0000.02%
Texas Yale Capital Corp. 16,000$221,0000.02%
Prospera Financial Services Inc 1,088$15,0000.01%
View complete list of LUMOS PHARMA INC shareholders